Traws Pharma, Inc. announced that positive data supporting the potential for ratutrelvir, a main protease inhibitor, as a treatment for COVID-19 ... 11 with hereditary angioedema (HAE).

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Sebetralstat is an investigational, novel oral plasma kallikrein inhibitor for the treatment of hereditary angioedema (HAE). We have filed multiple regulatory applications seeking approval of ...

PIK3CA-related overgrowth spectrum (PROS) is a rare genetic disorder that causes uncontrollable growth of parts of the body. Its symptoms vary greatly and affect children physically and ...

This is particularly evident in marketing. Before the COVID-19 pandemic, measuring engagement typically involved detailed follow-ups, contacting a pool of practitioners to gauge their awareness of ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). The modelling of the SARS-CoV-2 spatial ...

SALISBURY, England, March 03, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to laryngeal hereditary angioedema (HAE ...

• More mock-ups of iOS 19's new look have surface, though their accuracy is in dispute. • Apple has set a date for WWDC 2025 where we expect an iOS 19 preview. iOS 19 won't arrive for a few ...

Cincinnati, Ohio; Boulder, Colorado; and Salt Lake City/Park City, Utah, were among the finalist cities.

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for patients with hereditary angioedema. Read More New Chronic GVHD Treatments Show ...

Karen Capusan, DNP, CPNP-PC, discusses the current landscape of RSV ...